Intra-Cellular Therapies is an American biotechnology company focused on developing new therapeutic options for the treatment of neuropsychiatric disorders, including schizophrenia, bipolar disorder, and other mental health conditions. The company employs advanced technologies focused on cellular signaling and neurobiology to create innovative drugs that target specific molecular pathways in the brain. Intra-Cellular Therapies is known for its research in neurology and psychiatry, aiming to improve the lives of patients suffering from these challenging diseases.
Feed
There are no posts to show right now.
We use cookies to improve your experience on our site.
